文献速递呼吸道感染呼吸危重症与机械通气

COVID-19患者呼吸道SARS-CoV-2排毒动态取决于疾病严重程度

Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.
PubMed 文献 · Eur Respir J · 2021-07-20

该研究分析了92例COVID-19患者鼻咽和气管的SARS-CoV-2排毒情况,发现入院时重症与非重症患者初始排毒量无显著差异,但第二周重症患者排毒量持续升高,且47.8%患者排毒时间超过17天,与重症病程相关。

要点

  • 入院时重症与非重症COVID-19患者鼻咽排毒量无显著差异。
  • 住院第二周重症患者SARS-CoV-2排毒量仍升高,炎症反应更持久。
  • 47.8%患者排毒超过17天,其中73.2%为重症病例。

核心结论

  • 入院时重症与非重症COVID-19患者SARS-CoV-2排毒量无显著差异。
  • 住院第二周排毒量升高、全身炎症反应高峰延迟及排毒时间延长与更严重病程相关。

研究设计与样本

  • 对92例确诊COVID-19患者分析鼻咽和气管SARS-CoV-2排毒动态。
  • 入院时采集标准化鼻咽拭子或痰标本,机械通气患者额外采集气管吸取物。
  • 通过实时PCR检测SARS-CoV-2 RNA定量病毒排毒。

主要发现

  • 45%(41/92)患者为重症需机械通气。
  • 第1周鼻咽拭子初始排毒量在非重症与重症间无显著差异。
  • 第2周重症患者排毒量仍升高。
  • C反应蛋白、白介素-6和降钙素原时间曲线显示重症患者炎症反应更持久。
  • 47.8%患者排毒时间超过17天,其中73.2%为重症病程。

临床怎么用

  • 入院时排毒量不能区分重症风险,需动态监测第二周排毒及炎症指标。
  • 对排毒时间延长(>17天)患者应警惕重症病程可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A fraction of COVID-19 patients progress to a severe disease manifestation with respiratory failure and the necessity of mechanical ventilation. Identifying patients at risk is critical for optimised care and early therapeutic interventions. We investigated the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding relative to disease severity.We analysed nasopharyngeal and tracheal shedding of SARS-CoV-2 in 92 patients with diagnosed COVID-19. Upon admission, standardised nasopharyngeal swab or sputum samples were collected. If patients were mechanically ventilated, endotracheal aspirate samples were additionally obtained. Viral shedding was quantified by real-time PCR detection of SARS-CoV-2 RNA.45% (41 out of 92) of COVID-19 patients had a severe disease course with the need for mechanical ventilation (severe group). At week 1, the initial viral shedding determined from nasopharyngeal swabs showed no significant difference between nonsevere and severe cases. At week 2, a difference could be observed as the viral shedding remained elevated in severely ill patients. A time-course of C-reactive protein, interleukin-6 and procalcitonin revealed an even more protracted inflammatory response following the delayed drop of virus shedding load in severely ill patients. A significant proportion (47.8%) of patients showed evidence of prolonged viral shedding (>17 days), which was associated with severe disease courses (73.2%).We report that viral shedding does not differ significantly between severe and nonsevere COVID-19 cases upon admission to the hospital. Elevated SARS-CoV-2 shedding in the second week of hospitalisation, a systemic inflammatory reaction peaking between the second and third week, and prolonged viral shedding are associated with a more severe disease course.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Munker D, Osterman A, Stubbe H, et al. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur Respir J. 2021. PMID: 33602859. doi:10.1183/13993003.02724-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。